These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Should all stent patients have prolonged dual antiplatelet therapy? Kirtane AJ; King SB JACC Cardiovasc Interv; 2015 May; 8(6):873-875. PubMed ID: 25999115 [No Abstract] [Full Text] [Related]
3. Antiplatelet therapy in patients with coronary stent undergoing urologic surgery: is it still no man's land? Naspro R; Rossini R; Musumeci G; Gadda F; Pozzo LF Eur Urol; 2013 Jul; 64(1):101-5. PubMed ID: 23428067 [No Abstract] [Full Text] [Related]
4. The saga of the duration of dual antiplatelet therapy after drug-eluting stent placement. Helft G Arch Cardiovasc Dis; 2015 Oct; 108(10):469-71. PubMed ID: 26432274 [No Abstract] [Full Text] [Related]
6. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen). Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860 [TBL] [Abstract][Full Text] [Related]
7. Thirty days only double antiplatelet therapy after drug-eluting stenting: could a 'short-term' treatment be advantageous? Casella G; Resciniti E; Gallo P J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e21-e25. PubMed ID: 29045308 [No Abstract] [Full Text] [Related]
8. Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy. Kereiakes DJ; Yeh RW; Massaro JM; Driscoll-Shempp P; Cutlip DE; Steg PG; Gershlick AH; Darius H; Meredith IT; Ormiston J; Tanguay JF; Windecker S; Garratt KN; Kandzari DE; Lee DP; Simon DI; Iancu AC; Trebacz J; Mauri L; JACC Cardiovasc Interv; 2015 Oct; 8(12):1552-62. PubMed ID: 26493248 [TBL] [Abstract][Full Text] [Related]
9. The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview. Rubboli A; Faxon DP; Juhani Airaksinen KE; Schlitt A; Marín F; Bhatt DL; Lip GY Thromb Haemost; 2014 Dec; 112(6):1080-7. PubMed ID: 25298351 [TBL] [Abstract][Full Text] [Related]
11. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial. Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058 [TBL] [Abstract][Full Text] [Related]
12. Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds: A Review of the Published Data, Practical Recommendations, and Future Directions. Capodanno D; Angiolillo DJ JACC Cardiovasc Interv; 2017 Mar; 10(5):425-437. PubMed ID: 28279311 [TBL] [Abstract][Full Text] [Related]
13. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study. Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513 [TBL] [Abstract][Full Text] [Related]
14. Will We Ever Decide What Antithrombotic Regimen to Use After Stenting? King SB Cardiovasc Revasc Med; 2020 May; 21(5):702-703. PubMed ID: 32600799 [No Abstract] [Full Text] [Related]
15. Outcomes of preoperative bridging therapy for patients undergoing surgery after coronary stent implantation: a weighted meta-analysis of 280 patients from eight studies. Warshauer J; Patel VG; Christopoulos G; Kotsia AP; Banerjee S; Brilakis ES Catheter Cardiovasc Interv; 2015 Jan; 85(1):25-31. PubMed ID: 24740634 [TBL] [Abstract][Full Text] [Related]
16. Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention: The RECLOSE-3 Study (REsponsiveness to CLOpidogrel and StEnt Thrombosis). Valenti R; Marcucci R; Comito V; Marrani M; Cantini G; Migliorini A; Parodi G; Gensini GF; Abbate R; Antoniucci D JACC Cardiovasc Interv; 2015 Oct; 8(12):1563-70. PubMed ID: 26386764 [TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation. Musumeci G; Rossini R; Lettieri C; Capodanno D; Romano M; Rosiello R; Guagliumi G; Valsecchi O; Gavazzi A; Angiolillo DJ Catheter Cardiovasc Interv; 2012 Sep; 80(3):395-405. PubMed ID: 22109961 [TBL] [Abstract][Full Text] [Related]
18. High clopidogrel dose in patients with chronic kidney disease having clopidogrel resistance after percutaneous coronary intervention. Liang J; Wang Z; Shi D; Liu Y; Zhao Y; Han H; Li Y; Liu W; Zhang L; Yang L; Zhou Y Angiology; 2015 Apr; 66(4):319-25. PubMed ID: 24913197 [TBL] [Abstract][Full Text] [Related]
19. Reduced antiplatelet therapy after drug-eluting stenting: multicenter Janus Flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months-MATRIX study. Cassese S; De Luca G; Villari B; Berti S; Bellone P; Alfieri A; Montinaro A; Quaranta G; Marraccini P; Piscione F; Catheter Cardiovasc Interv; 2012 Sep; 80(3):408-16. PubMed ID: 21735531 [TBL] [Abstract][Full Text] [Related]